Correlation Between Exelixis and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Exelixis and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Exelixis and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Madrigal Pharmaceuticals.
Diversification Opportunities for Exelixis and Madrigal Pharmaceuticals
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Exelixis and Madrigal is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Exelixis i.e., Exelixis and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Exelixis and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Exelixis is expected to generate 1.06 times less return on investment than Madrigal Pharmaceuticals. But when comparing it to its historical volatility, Exelixis is 1.94 times less risky than Madrigal Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 25,079 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 9,439 from holding Madrigal Pharmaceuticals or generate 37.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Exelixis |
| Madrigal Pharmaceuticals |
Exelixis and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Madrigal Pharmaceuticals
The main advantage of trading using opposite Exelixis and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |